Results 131 to 140 of about 8,261 (192)

Comparative effectiveness of COVID-19 vaccines among health students, focusing on methodological concerns. [PDF]

Antimicrob Steward Healthc Epidemiol
Cakir B, Sertcelik A, Karadogan E, Uzar H, Temizer M, Kara SA, Ozden ME, Buzgan B, Ozyurek D, Alp A, Pinar A, Ayhan Baser D, Aksoy H, Fidanci I, Calik Basaran N, Ozyavuz Alp S, Arslan V, Sener B.   +17 more
europepmc   +1 more source

Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study. [PDF]

Med Sci Monit
Demirel Ç, Kibar F, Dağlıoğlu G, Çetiner S, Candevir A, İnal AS, Yücel Karakaya SP, Görüroğlu Öztürk Ö, Gümüş HH, İnal TC.   +9 more
europepmc   +1 more source

A predictive model for rapid assessment of protective efficacy against emerging SARS-CoV-2 variants. [PDF]

Infect Dis Model
Jin L, Jia S, Shao C, Shen R, Jin P, Li J.   +5 more
europepmc   +1 more source

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2. [PDF]

Vaccines (Basel)
Tangsathapornpong A, Nanthapisal S, Fukpho W, Bunjoungmanee P, Neamkul Y, Pontan K, Boonyarangkul A, Wanpen S, Thongphubeth K, Tharabenjasin P, Jaru-Ampornpan P.   +10 more
europepmc   +1 more source

Absence of autoantibodies linked to cancer and autoimmune disorders 26 weeks after BNT162b2 boosting in CoronaVac- primed individuals. [PDF]

Hum Vaccin Immunother
Mat Yassim AS, Mohd Hisham AA, Mohd Rosdan BS, Tan TM, Anuar ND, Mohamed Hashim EK, Norazmi MN.   +6 more
europepmc   +1 more source

Modeling of antibody waning after heterologous boosting with Ad5-nCoV in individuals primed with two-dose CoronaVac previously. [PDF]

Hum Vaccin Immunother
Shen R, Jin L, Peng X, Zhou Y, Jin P, Li J.   +5 more
europepmc   +1 more source

Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance study. [PDF]

BMC Infect Dis
Costa LB, Barreto FKA, Barbosa PPL, Almeida MM, Bekman ALS, Souza SS, Máximo ACBM, Silva DB, Alencar CH, Cavalcanti LPG.   +9 more
europepmc   +1 more source

Current status of intranasal and inhaled COVID-19 vaccines. [PDF]

NPJ Vaccines
Longet S, Paul S.
europepmc   +1 more source

Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil. [PDF]

Sci Rep
Borges MC, Palacios R, Conde MTRP, Volpe GJ, Ferreira NN, Garibaldi PMM, Fonseca BAL, Calado RT, Coutinho BM, Gomes BBM, de Lima Dias CFS, de Moraes GR, Haddad SK, de Miranda EJFP, Braga PE, Ragiotto L, França JID, de Lima MA, de Oliveira Alves LB, de Camargo Vieira Tenorio J, Sampaio SC, Covas DT, Dos Santos Almeida MAAL, Morandi Junior E, Boulos FC.   +24 more
europepmc   +1 more source

Baseline cohort profile: clinical and molecular characterisation of SARS-CoV-2 infected patients recruited into a longitudinal COVID-19 cohort study (COVGEN) in Malaysia. [PDF]

BMC Infect Dis
Azami NAM, Ooi JSM, Abdullah N, Nawi AM, Ahmad N, Hassan MR, Sulong A, Mokhtar MN, Periyasamy P, Kori N, Hamzah FA, Jamal SM, Hamid MFA, Mat WRW, Jarmin R, Hajib N, Selvam SBP, Arifin ASK, Mokhtar MFM, Goh YX, Yunos RIM, Ghaffar K, Ishak M, Shahri NAAM, Yusuf SNHM, Jalal NA, Ismail N, Yusuf NAM, Kamaruddin MA, Jamal R.   +29 more
europepmc   +1 more source